Mirko Stange

miacom diagnostics GmbH develops and distributes rapid molecular diagnostic tests for the identification of pathogens directly from patient material. Its products include hemoFISH Gram, hemoFISH Masterpanel, hemoFISH S.aureus and CNS Screen, respiFISH HAP Gram Panel, respiFISH HAP Masterpanel, FISH Probes, Combined hotplate and hybridization chamber, 8-channel pipette, and fluorescence microscopes. The company was founded by Ian Thrippleton and Walter Freiherr von Stein in 2009 and is headquartered in Düsseldorf, Germany.

Lino Biotech AG provides foal molography technology. It is a novel label-free biosensor platform for direct imaging of biomolecular interactions in living cells. The company was founded by Mirko Stange, Volker Gatterdam, and Andreas Fruter and is headquartered in Zurich, Switzerland.

Elastrin Therapeutics, Inc. is a biotech company based in Simpsonville, SC. Elastrin Therapeutics is developing novel therapies to reverse cardiovascular disease using a proprietary platform that targets and restores degraded elastin by removing harmful calcification that stiffens arteries. The platform significantly improves the efficacy of drugs and eliminates side effects by combining particle design with elastin targeting. The company's treatment, a nanoparticle that specifically targets elastin, is able to reverse calcification in the arteries and other tissues, providing a solution to heart disease, stroke, high blood pressure, COPD, and aneurysm. The company was founded by Mirko Stange, Douglas Mulhall, Naren Vyavahare, Charles D. Rice, Valentin Busch, and Markus Zils. The CEO is Matthias Breugelmans.

Ventac Partners GMBH offers life sciences consultancy services. Its consulting services include due diligence, education and training, market analysis, product development and valuation. The company was founded by Mikael Oerum in 2002 and is headquartered in Munich, Germany.